Trials / Unknown
UnknownNCT05742256
Oxycodone in Combination With Parathoracic Nerve Block is Used for Postoperative Analgesia in Lung Cancer
Effect of Oxycodone Combined With Ultrasound Guided Thoracic Paravertebral Nerve Block on Postoperative Analgesia in Patients With Lung Cancer Undergoing Thoracoscopic Surgery
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 159 (estimated)
- Sponsor
- Qianfoshan Hospital · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the effect of oxycodone combined with ultrasound-guided paravertebral nerve block on the postoperative analgesic effect of thoracoscopic lung cancer was investigated, and the effect and reasonable dose of oxycodone were explored, which provided a reference for the clinical multimodal analgesia after thoracoscopic lung cancer surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxycodone 1mg/kg | Test group 1 (OCA group):oxycodone 1mg/kg + flurbiprofen 50mg + ondansetron 16mg + 0.9% normal saline diluted to 100ml |
| DRUG | Oxycodone 1.5mg/kg | Test group 2 (OCB group): oxycodone 1.5mg/kg + flurbiprofen 50mg + ondansetron 16mg + 0.9% normal saline diluted to 100ml. |
| DRUG | Sufentanil | Control group (SF group): sufentanil 2ug/kg + flurbiprofen + ondansetron 16mg + 0.9% normal saline diluted to 100ml. |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2024-07-31
- Completion
- 2024-12-31
- First posted
- 2023-02-23
- Last updated
- 2023-02-23
Source: ClinicalTrials.gov record NCT05742256. Inclusion in this directory is not an endorsement.